Breakdown | |||||
TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|---|
Income Statement | Total Revenue | ||||
188.74M | 193.00M | 196.62M | 249.30M | 371.90M | 887.32M | Gross Profit |
139.20M | 143.24M | 149.94M | 159.56M | 240.48M | 534.19M | EBIT |
8.11M | 12.13M | 26.28M | -27.97M | -46.44M | -85.95M | EBITDA |
12.51M | 47.67M | 53.81M | 213.68M | 225.21M | 105.70M | Net Income Common Stockholders |
-4.76M | 1.21M | 45.97M | 142.61M | 99.74M | -172.60M |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
93.50M | 87.13M | 87.51M | 120.17M | 282.30M | 322.16M | Total Assets |
231.44M | 231.79M | 206.89M | 251.47M | 599.30M | 888.72M | Total Debt |
52.31M | 54.86M | 30.67M | 45.51M | 126.86M | 311.99M | Net Debt |
25.89M | -2.85M | -37.14M | -74.65M | -155.43M | -10.17M | Total Liabilities |
70.04M | 67.76M | 44.37M | 63.27M | 151.35M | 352.76M | Stockholders Equity |
161.41M | 164.04M | 162.52M | 188.19M | 447.95M | 535.96M |
Cash Flow | Free Cash Flow | ||||
61.52M | 32.94M | 68.44M | 57.08M | 155.42M | 269.19M | Operating Cash Flow |
74.46M | 44.71M | 71.58M | 59.47M | 158.95M | 293.72M | Investing Cash Flow |
-39.82M | -18.59M | -9.38M | 244.36M | 65.01M | 20.93M | Financing Cash Flow |
-42.00M | -36.22M | -102.85M | -465.96M | -255.29M | -187.08M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
84 Outperform | HK$265.05B | 4.22 | 24.28% | 16.98% | 30.58% | ― | |
64 Neutral | €79.79B | 24.25 | 28.95% | 5.29% | 4.79% | -11.38% | |
62 Neutral | $6.82B | 11.05 | 2.80% | 4.32% | 2.67% | -24.92% | |
50 Neutral | HK$446.55M | 8.53 | 3.77% | ― | -11.44% | 111.76% | |
48 Neutral | HK$102.87M | ― | -2.90% | ― | -7.14% | -110.87% | |
41 Neutral | $1.09B | ― | -95.62% | ― | -31.29% | 57.76% |